Todd M Morgan, MD
Jack Lapides M.D. Research Professor
Professor of Urology and Urologic Oncology Division Chief
Medical School
Available to mentor
Todd M Morgan, MD
Professor
Manage Your Profile
Qualifications
-
Urologic Oncology FellowshipVanderbilt University Medical Center, Urology, Nashville, United States
2009 - 2011
Clinical Fellowship
-
Urology ResidencyUniversity of Washington Medical Center, Urology, Seattle, United States
2004 - 2009
Residency
-
General Surgery InternshipUniversity of Washington Medical Center, Urology, Seattle, United States
2003 - 2004
Internship
Center Memberships
-
Center MemberTaubman Institute
-
Center MemberRogel Cancer Center
Recent Publications
-
Monda SM, Else T, Zhu A, Kaffenberger SD, Humble RM, Reichert ZR, Morgan TM, Chandrasekar T, Dominguez-Valentin M, Stoffel EM, Singhal U. Urol Oncol, 2026 Jul 30;Journal ArticleGermline testing in urothelial cancer: A narrative review of evidence, guidelines, and testing frameworks.
DOI:10.1016/j.urolonc.2026.07.004 -
Demus T, Ginsburg KB, Meah S, Daignault-Newton S, Labardee C, Johnson A, Hafron J, Peabody J, Dess R, Morgan T, Semerjian A, Borza T, Sarle R, Michigan Urological Surgical Collaboration . Urol Pract, 2026 Jul 2; 101097UPJ0000000000001055Journal ArticleAdjuvant Radiation Therapy Versus Initial Observation for Patients After Prostatectomy with Adverse Pathology: Have Findings from 3 Randomized Clinical Trials Influenced Clinical Practice?
DOI:10.1097/UPJ.0000000000001055 PMID: 42391301 -
Wang C-Y, Yapici H, Lilley J, Jiao W, Lodaya KJ, Li H, Morgan TM. Value in Health, 2026 Jun 28; 29 (6): s131Journal ArticleEE361 REAL-WORLD CTDNA TEST UTILIZATION AND ASSOCIATED COSTS IN US PATIENTS WITH BLADDER CANCER WHO UNDERWENT RADICAL CYSTECTOMY
DOI:10.1016/j.jval.2026.03.655 -
Monda SM, Meeks JJ, Powles T, Morgan TM. Journal of Urology, 2026 Apr 30; 215 (5S): e431Journal ArticleIP20-28 FREEDOM FROM BLADDER CANCER: TIME-TO-EVENT REPORTING IN CIS+ BCG-UNRESPONSIVE TRIALS
DOI:10.1097/01.ju.0001191388.74345.c9.28 -
Spratt DE, Srinivas S, Adra N, Ahmed B, An Y, Bitting R, Chapin B, Cheng HH, Cho SY, D'Amico AV, Desai N, Dorff T, Eastham JA, Farrington TA, Gao X, Gupta S, Ippolito JE, Karnes RJ, Kishan AU, Kuettel MR, Lang JM, Lee D, Lotan T, McDonald A, Morgan TM, Pessoa R, Rais-Bahrami S, Roach M, Robin T, Rosenfeld S, Scarpato KR, Seibert T, Shabsigh A, Szmulewitz R, Teply BA, Tward J, Valicenti R, VanderWeele D, Wong JK, Kovach E, Freedman-Cass D. Journal of the National Comprehensive Cancer Network Jnccn, 2026 May 1; 24 (5): 140 - 149.Journal ArticleNCCN Guidelines® Insights: Prostate Cancer, Version 5.2026
DOI:10.6004/jnccn.2026.0023 PMID: 42134408 -
Morgan TM, Lenz LH, Henriquez I, Monda SM, García-Pablo R, Clegg W, Finch R, Mabey B, Britton C, Crawford ED, Lewicki P, Punnen S, Shore ND, Tosoian JJ, Jasper J, Gutin A, Schiewer MJ, Tward JD. Clinical Genitourinary Cancer, 2026 May 22; 102586 - 102586.Journal ArticleRobust meta-analysis of a clinical cell-cycle risk (CCR) score demonstrates broadly applicable metastasis and disease-specific mortality risk stratification in men with localized prostate cancer
DOI:10.1016/j.clgc.2026.102586 -
Couvillon A, Turkbey B, Choyke P, Lee-Wisdom K, McKinney Y, Friedman SJ, Rosner I, Kaltman RD, Sidlow R, Mullane MP, Giri VN, Morgan TM, Cheng HH, Merino M, Figg WD, Pinto PA, Dahut WL, Karzai F. Journal of Clinical Oncology, 2026 Mar 4; 44 (7_suppl): 315 - 315.Journal ArticleInherited risk for prostate cancer (PCa): Following the natural history of men with increased genetic risk using multiparametric MRI (mpMRI).
DOI:10.1200/jco.2026.44.7_suppl.315 -
Odayar V, Monda S, Yin H, Gonzalez RT, Casas SJ, Hopfensperger K, Kendrick D, Mietzel MA, Mislmani M, Zaki MA, McLaughlin PW, Morgan TM, Jackson WC, Schipper MJ, Heimburger DK, Bryant AK, Pierce LJ, Borza T, Dess RT. Journal of Clinical Oncology, 2026 Mar 4; 44 (7_suppl): 336 - 336.Proceeding / Abstract / PosterPopulation-level trends in radiation treatment of low-risk prostate cancer.
DOI:10.1200/jco.2026.44.7_suppl.336
Featured News & Stories
Department News
Dr. Ben Pockros and Dr. Todd Morgan Featured in Medscape Article
Dr. Ben Pockros and Dr. Todd Morgan Featured in Article Examining Contrast-Free MRI for Prostate Cancer
Health Lab
Active surveillance helps men avoid unnecessary surgery for prostate cancer
About one in eight men in the United States are diagnosed with prostate cancer during their lifetime. However, each man’s risk can vary based on age, race, family history and lifestyle. Todd Morgan answers questions about the different stages of prostate cancer, when active surveillance is preferred and why surgical interventions can be harmful.
Department News
ASPI Honors Dr. Todd Morgan for Patient Advocacy
On August 2, 2025, Dr. Todd Morgan will be recognized with ASPI’s 2025 Special Award for Advocacy for his courageous stand during a pivotal moment in prostate cancer care.
Health Lab
After prostate cancer surgery, 70-year-old track and field athlete takes on international competition
Just 8 months after undergoing robotic surgery to remove his cancerous prostate, Mark Cwiek, a 70-year-old track and field athlete, successfully competed in the World Masters Athletics Championship.
Department News
Dr. Morgan Featured on BackTable Urology Podcast
Todd Morgan, Professor of Urology, discussed his SUO fellowship experience on BackTable Urology.
Department News
Weiser Center for Prostate Cancer Celebration
The Weiser Center for Prostate Cancer celebrated its programs, patient advocates, and all the prostate care team members across multiple departments and care team roles.
